KalVista Pharmaceuticals
KALV
KALV
20 hedge funds and large institutions have $51.4M invested in KalVista Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
75% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 8
Holders
20
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$21.4M | |
| 2 | +$19M | |
| 3 | +$4.36M | |
| 4 |
VMI
VHCP Management II
New York
|
+$1.63M |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$121K |
Top Sellers
| 1 | -$112K | |
| 2 | -$50.6K | |
| 3 | -$45K | |
| 4 |
Goldman Sachs
New York
|
-$44K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$30K |